Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$41.04 - $56.79 $502,616 - $695,507
-12,247 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$36.42 - $57.0 $446,035 - $698,079
12,247 New
12,247 $505,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.62B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Round Table Services, LLC Portfolio

Follow Round Table Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Table Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Table Services, LLC with notifications on news.